<DOC>
	<DOCNO>NCT00174382</DOCNO>
	<brief_summary>To document effectiveness , safety , tolerability donepezil patient mixed AD/VaD , document effectiveness , safety , tolerability donepezil patient VaD . The effect donepezil executive functioning , behavior , general cognition , ADLs global functioning assess .</brief_summary>
	<brief_title>Vaspect Study - An Open-Label Trial Of Donepezil Vascular Mixed Dementia</brief_title>
	<detailed_description>The trial terminate October 15 , 2007 due difficulty recruit subject . There safety efficacy concern regard study medication decision terminate trial .</detailed_description>
	<mesh_term>Dementia</mesh_term>
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Dementia , Vascular</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Subjects must meet DSMIVTR criterion clinical diagnosis Vascular Dementia clinical diagnosis dementia due multiple etiology . Subjects must reliable caregiver family member agree accompany subject schedule visit , provide information subject require . Subjects current primary psychiatric diagnosis dementia Alzheimer 's type Vascular Dementia .</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
</DOC>